August 25th, 2020
Harvard University, AbbVie form research alliance to address emergent viral diseases
Commitment of $30M from AbbVie supports research collaboration with Harvard Medical School to advance development of therapeutics
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Therapeutics
July 22nd, 2020
A versatile vessel for next-gen therapeutics
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
May 7th, 2019
Harvard University, Broad Institute extend CRISPR human therapeutics license to Verve Therapeutics
Agreement enables development of genome-based therapies to protect against heart disease in adults
March 13th, 2019
Harvard and Deerfield establish Lab1636, a major translational research alliance
Deerfield commits $100M to inject fuel into translational life science research at Harvard
October 19th, 2017
Heading off the post-antibiotic age
Second annual Harvard FUSION symposium explores the Science and Business of Combating Antibiotic Resistance
